Alemtuzumab and pancytopenia Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5694796-9
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection , bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.

Alemtuzumab Side Effects Report #5695685-6
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection , bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.

Alemtuzumab Side Effects Report #4925247-7
Alemtuzumab side effect was reported by a Pharmacist from UNITED STATES on Feb 22, 2006. Male patient, 49 years of age, was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, hepatic necrosis, histoplasmosis disseminated, multi-organ failure, pancytopenia, respiratory failure, systemic inflammatory response syndrome. Alemtuzumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE, PREDNISONE, TACROLIMUS, TRIMETHOPRIM, VALGANCICLOVIR, CLOTRIMAZOLE, CALCIUM GLUCONATE, DOCUSATE. Patient recovered.